4.8 Article

Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1311183110

关键词

circular plant peptide; peptide ligand design; uterotonic; chemical pharmacology; peptide drugs

资金

  1. Austrian Science Fund [P22889-B11]
  2. European Union [254897]
  3. Austrian Science Fund (FWF) [P22889] Funding Source: Austrian Science Fund (FWF)
  4. Austrian Science Fund (FWF) [P 22889] Funding Source: researchfish

向作者/读者索取更多资源

Cyclotides are plant peptides comprising a circular backbone and three conserved disulfide bonds that confer them with exceptional stability. They were originally discovered in Oldenlandia affinis based on their use in traditional African medicine to accelerate labor. Recently, cyclotides have been identified in numerous plant species of the coffee, violet, cucurbit, pea, potato, and grass families. Their unique structural topology, high stability, and tolerance to sequence variation make them promising templates for the development of peptide-based pharmaceuticals. However, the mechanisms underlying their biological activities remain largely unknown; specifically, a receptor for a native cyclotide has not been reported hitherto. Using bioactivity-guided fractionation of an herbal peptide extract known to indigenous healers as kalata-kalata, the cyclotide kalata B7 was found to induce strong contractility on human uterine smooth muscle cells. Radioligand displacement and second messenger-based reporter assays confirmed the oxytocin and vasopressin V-1a receptors, members of the G protein-coupled receptor family, as molecular targets for this cyclotide. Furthermore, we show that cyclotides can serve as templates for the design of selective G protein-coupled receptor ligands by generating an oxytocin-like peptide with nanomolar affinity. This nonapeptide elicited dose-dependent contractions on human myometrium. These observations provide a proof of concept for the development of cyclotide-based peptide ligands.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Toxicology

Antinociceptive peptides from venomous arthropods

Jessica A. I. Muller, Lai Y. Chan, Monica C. Toffoli-Kadri, Marcia R. Mortari, David J. Craik, Johannes Koehbach

Summary: This review highlights the structural diversity of antinociceptive arthropod peptides and emphasizes their vast potential for the discovery of novel analgesic lead molecules.

TOXIN REVIEWS (2023)

Review Pharmacology & Pharmacy

Pharmacological Interventions in Labor and Delivery

Susan Wray, Sarah Arrowsmith, Andrew Sharp

Summary: Although there are not many pregnancy-specific drugs, there are specific high-risk areas in obstetric care where unique pharmacological approaches have been established. These approaches have become the foundation for managing preterm birth, labor induction and augmentation, and postpartum hemorrhage. This review summarizes the existing evidence supporting and expanding these pharmacological approaches and their impact on clinical practice, including both established and emerging therapeutic options.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2023)

Article Chemistry, Medicinal

Discovery, Characterization, and Engineering of LvIC, an α4/4-Conotoxin That Selectively Blocks Rat α6/α3β4 Nicotinic Acetylcholine Receptors

Xiaopeng Zhu, Shuai Wang, Quentin Kaas, Jinpeng Yu, Yong Wu, Peta J. Harvey, Dongting Zhangsun, David J. Craik, Sulan Luo

Summary: The researchers characterized a novel alpha-conotoxin, LvIC, and its analogues to probe structure-activity relationships at the alpha 6 beta 4 nAChR. They found a potent and specific antagonist, [D1G,delta Q14]LvIC, which could potentially serve as a novel molecular probe to explore alpha 6 beta 4 nAChR-related neurophysiological and pharmacological functions.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

A Chemoenzymatic Approach To Produce a Cyclic Analogue of the Analgesic Drug MVIIA (Ziconotide)

Yan Zhou, Peta J. Harvey, Johannes Koehbach, Lai Yue Chan, Alun Jones, Asa Andersson, Irina Vetter, Thomas Durek, David J. Craik

Summary: In this study, a novel method using asparaginyl endopeptidase (AEP)-mediated cyclization was successfully employed to generate backbone cyclic analogues of MVIIA. These cyclic analogues showed improved pharmaceutical properties, including enhanced stability and inhibition of calcium channels. This study highlights the potential of AEP transpeptidases in cyclizing complex peptides and improving the therapeutic value of conotoxins.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Article Biochemistry & Molecular Biology

Captivity induces a sweeping and sustained genomic response in a starfish

Marie Morin, Mathias Joesson, Conan K. Wang, David J. Craik, Sandie M. Degnan, Bernard M. Degnan

Summary: This study investigates the impact of captivity on the physiology and health of crown-of-thorns starfish by comparing gene expression in wild and captive individuals. The results show significant differences in gene expression between wild and captive starfish, with genes involved in oxidative stress and energy metabolism upregulated in captivity. This suggests that caution should be taken when extrapolating results from captive marine animals to their wild counterparts.

MOLECULAR ECOLOGY (2023)

Review Biochemistry & Molecular Biology

Native and Engineered Cyclic Disulfide-Rich Peptides as Drug Leads

Tristan J. Tyler, Thomas Durek, David J. Craik

Summary: Bioactive peptides are a diverse group of molecules with varied structures and functions. However, their use as drug candidates has been limited due to inherent shortcomings, including short half-lives and poor cell permeability. This review explores the use of molecular engineering to insert bioactive sequences into constrained scaffolds with desired pharmaceutical properties. Specifically, the focus is on cyclic disulfide-rich scaffolds, either naturally derived or engineered, which are intrinsically stable and amenable to sequence modifications, making them privileged frameworks in drug design.

MOLECULES (2023)

Article Biochemical Research Methods

Plant-based production of an orally active cyclotide for the treatment of multiple sclerosis

Mark A. A. Jackson, Jing Xie, Linh T. T. Nguyen, Xiaohan Wang, Kuok Yap, Peta J. J. Harvey, Edward K. K. Gilding, David J. J. Craik

Summary: Multiple sclerosis (MS) is a debilitating disease that requires prolonged treatment. The experimental therapeutic [T20K]kB1, a mutant of a plant peptide, shows promise for oral dosing and stability due to its cyclic structure. This study demonstrates the production of [T20K]kB1 in the Nicotiana benthamiana plant, providing a sustainable and cost-effective production method for cyclotide-based therapeutics.

TRANSGENIC RESEARCH (2023)

Article Entomology

Towards a Sustainable Management of the Spotted-Wing Drosophila: Disclosing the Effects of Two Spider Venom Peptides on Drosophila suzukii

Laura Regalado, Sara Sario, Rafael J. J. Mendes, Javier Valle, Peta J. J. Harvey, Catia Teixeira, Paula Gomes, David Andreu, Conceicao Santos

Summary: In this study, the biological activity of two underexplored spider venom peptides (J-atracotoxin-Hv1c and mu-theraphotoxin-Hhn2b) against adult D. suzukii flies was assessed, as well as the biological response of flies to these peptides through detoxification mechanisms. Results demonstrate that mu-theraphotoxin-Hhn2b enhanced fly longevity. Gene expression analysis suggests that detoxification and stress-related mechanisms are triggered in D. suzukii flies in response to treatment with these peptides. Our results highlight the potential of venom peptides to control D. suzukii and how to ultimately devise improved target-specific formulations.

INSECTS (2023)

Article Immunology

Heparan sulfate regulates IL-21 bioavailability and signal strength that control germinal center B cell selection and differentiation

Zhian Chen, Yanfang Cui, Yin Yao, Bo Liu, Joseph Yunis, Xin Gao, Naiqi Wang, Pablo F. Canete, Zewen Kelvin Tuong, Hongjian Sun, Hao Wang, Siling Yang, Runli Wang, Yew Ann Leong, David Simon Davis, Jiahuan Qin, Kaili Liang, Jun Deng, Conan K. Wang, Yen-Hua Huang, Jonathan A. Roco, Sam Nettelfield, Huaming Zhu, Huajun Xu, Zhijia Yu, David Craik, Zheng Liu, Hai Qi, Christopher Parish, Di Yu

Summary: In antibody responses, mutated germinal center B (BGc) cells are positively selected for reentry or differentiation, with the support of TFH cell-derived signals including CD40 and IL-21. The binding and signaling of IL-21 in BGc cells is reduced compared to non-BGc cells, due to low cellular heparan sulfate (HS) sulfation. Ndst1-mediated N-sulfation of HS in B cells promotes IL-21 binding and signal strength, and selective desensitization to IL-21 occurs in BGc cells. Therefore, the biochemical regulation of IL-21 availability and signal strength plays a crucial role in GC selection.

SCIENCE IMMUNOLOGY (2023)

Article Chemistry, Medicinal

Development of Melanocortin 4 Receptor Agonists by Exploiting Animal-Derived Macrocyclic, Disulfide-Rich Peptide Scaffolds

Edin Muratspahic, Despoina Aslanoglou, Andrew M. White, Claudia Draxler, Xaver Kozisek, Zara Farooq, David J. Craik, Peter J. McCormick, Thomas Durek, Christian W. Gruber

Summary: In this study, peptide ligands for MC4R were designed using a peptide drug design approach. The designed peptides fully activated MC4R and recruited beta-arrestin-2 with higher efficacies and potencies than the endogenous alpha-MSH. These findings suggest the potential of these novel peptide ligands in developing safer and more effective antiobesity drugs.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

Article Plant Sciences

Exploring the Limits of Cyanobactin Macrocyclase PatGmac: Cyclization of PawS-Derived Peptide Sunflower Trypsin Inhibitor-1 and Cyclotide Kalata B1

Taj Muhammad, Wael E. Houssen, Louise Thomas, Cristina-Nicoleta Alexandru-Crivac, Sunithi Gunasekera, Marcel Jaspars, Ulf Goransson

Summary: The subtilisin-like macrocyclase PatGmac, produced by Prochloron didemni, is involved in the biosynthesis of patellamides. It recognizes and cyclizes precursor peptides with a specific recognition motif, resulting in the formation of the native macrocyclic patellamide. In this study, we investigate the potential use of PatGmac in cyclizing larger peptides, namely SFTI-1 and kalata B1.

JOURNAL OF NATURAL PRODUCTS (2023)

Review Chemistry, Multidisciplinary

Nanomedicine strategies to improve therapeutic agents for the prevention and treatment of preterm birth and future directions

Jessica Taylor, Andrew Sharp, Steve P. Rannard, Sarah Arrowsmith, Tom O. McDonald

Summary: The WHO estimates that 15 million babies are born preterm each year, resulting in 1 million infant mortalities and long-term health issues. While progress has been made in understanding the causes of preterm birth and developing therapeutic options such as progesterone or uterine contraction suppressants, the number of preterm births continues to rise. This review highlights the urgent need for alternative and improved therapeutic systems for preterm birth, specifically focusing on the potential of nanomedicine to enhance the efficacy and address current drawbacks of existing therapeutics. Different nanomedicines, including liposomes, lipid-based carriers, polymers, and nanosuspensions, are discussed, along with their significance in improving existing therapeutic agents in obstetrics. The review also explores the potential repurposing of other pharmaceutical agents with tocolytic properties for preterm birth treatment.

NANOSCALE ADVANCES (2023)

Article Biochemistry & Molecular Biology

Enhancing the Stability of Tumor Homing LyP-1 Peptide Using Cyclization and Retro Grafting Strategies

Seyda Kara, Elif Ayazoglu Demir, Selcen Celik Uzuner, Muharrem Akcan

Summary: Anticancer peptide therapeutics have the potential to be effective in cancer treatment due to their specificity and tumor-homing abilities. This study aims to enhance the stability of the LyP-1 peptide in serum using cyclization and grafting strategies. The results show that the cyclic homodimer LyP-1 peptide exhibits extraordinary stability, and the retro grafted peptides also show improved stability.

INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2023)

暂无数据